Sign In
test

Fayth Ecker

Act Capital Management, Llc

Assets Managed
$127.235M
Holdings
56
Last Quarter
2026 - Q1
Filed Date
1mo 12d ago
Growth Rate
2.89%(2Q avg: 36.79%)
Sustained Growth
3 quarters

Portfolio positions

This chart displays the top 10 holdings in Act Capital Management, Llc's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 56 positions.

Assets under management

The assets under management (AUM) of Act Capital Management, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 3 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 127.235M in assets, with a quarterly growth rate of 2.89% and a 2-quarter average growth rate of 36.79%. The portfolio is managed by Fayth Ecker, and others.

Portfolio holdings

InvestmentPortfolio %Reported Value
KRYS
Krystal Biotech Inc
Recent Activity
Decreased -0.03%
12.28%
$15.622M
60,477 shares@ $258.33 avg price
CVX
Chevron Corp
Recent Activity
Decreased -4.45%
12.2%
$15.518M
75,000 shares@ $206.9 avg price
XOM
Exxon Mobil Corp
Recent Activity
Decreased -15.15%
9.34%
$11.876M
70,000 shares@ $169.66 avg price
CELC
Celcuity Inc
Recent Activity
Increased 44.57%
8.23%
$10.464M
91,675 shares@ $114.15 avg price
TGTX
Tg Therapeutics Inc
Recent Activity
Decreased -7.38%
6.51%
$8.273M
249,025 shares@ $33.23 avg price
ABVX
Abivax Sa-adr
Recent Activity
Increased 10.96%
6.21%
$7.895M
70,900 shares@ $111.35 avg price
AMZN
Amazon.com Inc
Recent Activity
Increased 34.15%
5.41%
$6.873M
33,000 shares@ $208.27 avg price
VKTX
Viking Therapeutics Inc
Recent Activity
Increased 1.56%
5.36%
$6.811M
209,300 shares@ $32.54 avg price
ARWR
Arrowhead Pharmaceuticals In
Recent Activity
Increased 10%
4.07%
$5.173M
82,500 shares@ $62.7 avg price
NKTR
Nektar Therapeutics
Recent Activity
Increased 38.48%
4.01%
$5.101M
70,900 shares@ $71.95 avg price

1-10 of 56